Research
Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study
BMJ 2017; 356 doi: https://doi.org/10.1136/bmj.j791 (Published 09 March 2017) Cite this as: BMJ 2017;356:j791Data supplement
Web Extra
- Data Supplement - Supplementary tables and figure
Related articles
- Research Published: 18 November 2020; BMJ 371 doi:10.1136/bmj.m4080
See more
- Introductory AddressProv Med Surg J October 03, 1840, s1-1 (1) 1-4; DOI: https://doi.org/10.1136/bmj.s1-1.1.1
- Report of the Meeting of the Eastern Branch of the Provincial Association at Bury St. Edmond'sProv Med Surg J October 03, 1840, s1-1 (1) 10-13; DOI: https://doi.org/10.1136/bmj.s1-1.1.10
- Mr. Warburton's Bill for the Regulation of the Medical ProfessionProv Med Surg J October 03, 1840, s1-1 (1) 13-15; DOI: https://doi.org/10.1136/bmj.s1-1.1.13
- An Atlas of Plates, illustrative of the Principles and Practice of Obstetric Medicine and Surgery, with descriptive LetterpressProv Med Surg J October 03, 1840, s1-1 (1) 4; DOI: https://doi.org/10.1136/bmj.s1-1.1.4
- A Practical Treatise on the Diseases peculiar to Women, illustrated by Cases, &cProv Med Surg J October 03, 1840, s1-1 (1) 4-5; DOI: https://doi.org/10.1136/bmj.s1-1.1.4-a
Cited by...
- Impact of ACEIs and ARBs-related adverse drug reaction on patients clinical outcomes: a cohort study in UK primary care
- Seasonal variation of serum potassium and related prescription pattern: an ecological time series
- Pharmacological Targeting of Mitochondria in Diabetic Kidney Disease
- Optimizing Renin-Angiotensin System Inhibitor Use in CKD
- Sex- and Gender-Based Pharmacological Response to Drugs
- First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care
- Managing hypertension in primary care
- Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes
- ACE inhibitors and ARBs: Managing potassium and renal function
- Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?
- Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus
- Renal function after new treatment with renin-angiotensin system blockers